ArticleInternational journal of general medicine2022

CBX3 is a Prognostic Biomarker Correlated with ATR Activation and Immune Infiltration in Head and Neck Squamous Cell Carcinoma.

Xu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.